Receptors, Natural Killer Cell
"Receptors, Natural Killer Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Receptors that are specifically found on the surface of NATURAL KILLER CELLS. They play an important role in regulating the cellular component of INNATE IMMUNITY.
Descriptor ID |
D055607
|
MeSH Number(s) |
D12.776.543.750.705.895
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Natural Killer Cell".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Natural Killer Cell".
This graph shows the total number of publications written about "Receptors, Natural Killer Cell" by people in this website by year, and whether "Receptors, Natural Killer Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 2 | 2 |
2017 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Natural Killer Cell" by people in Profiles.
-
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells. Front Immunol. 2021; 12:626098.
-
Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor. Sci Rep. 2019 05 15; 9(1):7426.
-
High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults. PLoS One. 2017; 12(8):e0181134.
-
Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia. Haematologica. 2014 May; 99(5):836-47.
-
The adaptor protein Crk controls activation and inhibition of natural killer cells. Immunity. 2012 Apr 20; 36(4):600-11.
-
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity. 2008 Apr; 28(4):571-80.
-
Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer. J Immunol. 2005 Oct 15; 175(8):5541-50.
-
Interleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium. J Infect Dis. 2005 Oct 01; 192(7):1294-302.
-
The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions. Blood. 2005 Nov 15; 106(10):3666-72.
-
Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells. J Immunol. 2005 Feb 15; 174(4):1922-31.